Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
Sponsor: Biocad
Summary
The goal of this multicenter, two-stage, open-label study is to investigate the safety, immunogenicity, and efficacy of ANB-010 in subjects with hemophilia A. The study will have a dose-escalation design with elements of phase I/II seamless adaptive design.
Official title: An Open-Label Two-Stage Trial of the Safety, Pharmacodynamics, Biodistribution, Immunogenicity and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-07-26
Completion Date
2033-06
Last Updated
2025-04-24
Healthy Volunteers
No
Conditions
Interventions
ANB-010, dose 1
Adeno-associated viral vector carrying the FVIII gene single infusion at dose 1.
ANB-010, dose 2
Adeno-associated viral vector carrying the FVIII gene single infusion at dose 2.
ANB-010, dose 3
Adeno-associated viral vector carrying the FVIII gene single infusion at dose 3.
Locations (17)
State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital"
Chelyabinsk, Russia
State budgetary healthcare institution Leningrad Regional Clinical Hospital
Gatchina, Russia
Kuzbass Clinical Hospital named after S.V. Belyaev
Kemerovo, Russia
Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency"
Kirov, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders)
Moscow, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia)
Moscow, Russia
Research Center for Hematology MHSD RF
Moscow, Russia
Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin"
Moscow, Russia
LLC "Medis"
Nizhny Novgorod, Russia
State Novosibirsk Regional Clinical Hospital
Novosibirsk, Russia
Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency
Saint Petersburg, Russia
City Polyclinic №37
Saint Petersburg, Russia
Almazov National Medical Research Centre
Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian Federation
Samara, Russia
State Institution "Komi Republican Oncological Dispensary"
Syktyvkar, Russia
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation
Ufa, Russia
State Autonomous Institution for Healthcare of Sverdlovsk region "Sverdlovsk Regional Clinical Hospital №1"
Yekaterinburg, Russia